Servier at ASH meeting to present new data in hematology research
All the news from Servier Group
Primary Sjögren’s syndrome: completion of patient enrollment in Phase 2a clinical trial
Spartners: Biotech start-up welcome to apply!
Servier unveils its 2030 ambition and reveals a new visual identity
Parkinson: Servier exercises the exclusive licensing option on collaborative program with Oncodesign Precision Medicine
Servier collaborates in the treatment of pancreatic cancer
Servier is boosting its digital transformation with Google Cloud!
Servier presents its oncology activities at the ESMO Congress
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader